Board of Directors

Sebastian Lombardo

Chairman of the Board of Directors
Read More

Sebastian is a serial entrepreneur with extensive and successful experience in creating, leading and scaling several companies in the Technology sector. He is the former Chairman and CEO of Valtech, a digital transformation agency he built into a world leading company and sold to a private equity firm in 2021. Sebastian has been the main investor in Smart Immune since inception. Additionally, Sebastian serves on the board of DKMS, the world's largest bone marrow donor registry.

Jean-Pierre Bizzari

Observer
Read More

Jean-Pierre Bizzari is a highly experienced oncologist who has been successfully bringing innovative cancer treatments to market for over 35 years, overseeing clinical development in companies including Rhône-Poulenc, Sanofi-Aventis, Celgene, Servier and Halozyme. Dr Bizzari is a member of the Scientific Advisory Board of the French National Cancer Institute and the Board of the European Organization for Research and Treatment of Cancer, as well as serving as the Chairman of its New Drug Committee. He is on the Boards of Halozyme, ADC Therapeutics and Aprea Therapeutics and an Observer on the Board of Directors at Smart Immune.

Pablo Silveri

Independent member, CFO and co-founder of Nuqlea
Read More

Pablo Silveri is the Chief Finance Officer and Co-founder of Nuqlea, a B2B digital marketplace for construction and habitat, and Smart Immune’s former Chief Financial Officer. Pablo is a corporate finance expert who held managing roles at the Dow Chemical Company, where he worked for 25 years. Before joining Smart Immune in 2019, Pablo was the Latin America Finance Director at Dow. He is also a Board member of the Spanish company, Auravant.